4.5 Article

Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle

Journal

HUMAN MOLECULAR GENETICS
Volume 17, Issue 12, Pages 1855-1866

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddn081

Keywords

-

Funding

  1. Medical Research Council [G0601943] Funding Source: researchfish
  2. Medical Research Council [G0601943] Funding Source: Medline
  3. NIAMS NIH HHS [R21-AR48327-01] Funding Source: Medline
  4. MRC [G0601943] Funding Source: UKRI

Ask authors/readers for more resources

Muscular dystrophies comprise a genetically heterogeneous group of degenerative muscle disorders characterized by progressive muscle wasting and weakness. Two forms of limb-girdle muscular dystrophy, 2A and 2B, are caused by mutations in calpain 3 (CAPN3) and dysferlin (DYSF), respectively. While CAPN3 may be involved in sarcomere remodeling, DYSF is proposed to play a role in membrane repair. The coexistence of CAPN3 and AHNAK, a protein involved in subsarcolemmal cytoarchitecture and membrane repair, in the dysferlin protein complex and the presence of proteolytic cleavage fragments of AHNAK in skeletal muscle led us to investigate whether AHNAK can act as substrate for CAPN3. We here demonstrate that AHNAK is cleaved by CAPN3 and show that AHNAK is lost in cells expressing active CAPN3. Conversely, AHNAK accumulates when calpain 3 is defective in skeletal muscle of calpainopathy patients. Moreover, we demonstrate that AHNAK fragments cleaved by CAPN3 have lost their affinity for dysferlin. Thus, our findings suggest interconnectivity between both diseases by revealing a novel physiological role for CAPN3 in regulating the dysferlin protein complex.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available